| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
|
2020
|
1.40
|
|
2
|
Post-recovery enhancement of anti-variant neutralisation after severe COVID-19.
|
2022
|
0.75
|
|
3
|
Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults.
|
2022
|
0.75
|
|
4
|
Prevalence of nasopharyngeal carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015-17.
|
2022
|
0.75
|
|
5
|
The interplay between community and hospital clones within health-care settings: a genomic analysis.
|
2022
|
0.75
|
|
6
|
Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.
|
2020
|
0.75
|
|
7
|
Start as we mean to go on.
|
2020
|
0.75
|
|
8
|
Correction to 2020; published online May 8. https://doi.org/10.1016/S2666-5247(20)30027-6.
|
2020
|
0.75
|
|
9
|
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study.
|
2022
|
0.75
|
|
10
|
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
|
2020
|
0.75
|